Industry Growth Insights published a new data on “Prostate-Specific Antigen (PSA) Test Market”. The research report is titled “Prostate-Specific Antigen (PSA) Test Market research by Types (CLIA, ELISA, Other), By Applications (Screening, Post-treatment Monitoring, Other), By Players/Companies Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prostate-Specific Antigen (PSA) Test Market Research Report
By Type
CLIA, ELISA, Other
By Application
Screening, Post-treatment Monitoring, Other
By Companies
Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
 Test Industry Outlook.svg)
Global Prostate-Specific Antigen (PSA) Test Market Report Segments:
The global Prostate-Specific Antigen (PSA) Test market is segmented on the basis of:
Types
CLIA, ELISA, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Screening, Post-treatment Monitoring, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Siemens Healthcare
- DiaSorin
- Roche
- Beckman Coulter
- PerkinElmer
- Tosoh
- Ortho Clinical
- Fujirebio
- Mediwatch (LABORIE)
- BodiTech
 Test Market Overview.svg)
Highlights of The Prostate-Specific Antigen (PSA) Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CLIA
- ELISA
- Other
- By Application:
- Screening
- Post-treatment Monitoring
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prostate-Specific Antigen (PSA) Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Test Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The PSA test is a blood test that measures the level of prostate-specific antigen (PSA) in a person's blood. The higher the PSA level, the more likely it is that the person has prostate cancer.
Some of the key players operating in the prostate-specific antigen (psa) test market are Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prostate-Specific Antigen (PSA) Test Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prostate-Specific Antigen (PSA) Test Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prostate-Specific Antigen (PSA) Test Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prostate-Specific Antigen (PSA) Test Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prostate-Specific Antigen (PSA) Test Market Size & Forecast, 2018-2028
4.5.1 Prostate-Specific Antigen (PSA) Test Market Size and Y-o-Y Growth
4.5.2 Prostate-Specific Antigen (PSA) Test Market Absolute $ Opportunity
Chapter 5 Global Prostate-Specific Antigen (PSA) Test Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
5.2.1 CLIA
5.2.2 ELISA
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Prostate-Specific Antigen (PSA) Test Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
6.2.1 Screening
6.2.2 Post-treatment Monitoring
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prostate-Specific Antigen (PSA) Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prostate-Specific Antigen (PSA) Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Prostate-Specific Antigen (PSA) Test Analysis and Forecast
9.1 Introduction
9.2 North America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
9.6.1 CLIA
9.6.2 ELISA
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
9.10.1 Screening
9.10.2 Post-treatment Monitoring
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Prostate-Specific Antigen (PSA) Test Analysis and Forecast
10.1 Introduction
10.2 Europe Prostate-Specific Antigen (PSA) Test Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
10.6.1 CLIA
10.6.2 ELISA
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
10.10.1 Screening
10.10.2 Post-treatment Monitoring
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Prostate-Specific Antigen (PSA) Test Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
11.6.1 CLIA
11.6.2 ELISA
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
11.10.1 Screening
11.10.2 Post-treatment Monitoring
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Prostate-Specific Antigen (PSA) Test Analysis and Forecast
12.1 Introduction
12.2 Latin America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
12.6.1 CLIA
12.6.2 ELISA
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
12.10.1 Screening
12.10.2 Post-treatment Monitoring
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Prostate-Specific Antigen (PSA) Test Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Prostate-Specific Antigen (PSA) Test Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Prostate-Specific Antigen (PSA) Test Market Size Forecast by Type
13.6.1 CLIA
13.6.2 ELISA
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Prostate-Specific Antigen (PSA) Test Market Size Forecast by Applications
13.10.1 Screening
13.10.2 Post-treatment Monitoring
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prostate-Specific Antigen (PSA) Test Market: Competitive Dashboard
14.2 Global Prostate-Specific Antigen (PSA) Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Siemens Healthcare
14.3.3 DiaSorin
14.3.4 Roche
14.3.5 Beckman Coulter
14.3.6 PerkinElmer
14.3.7 Tosoh
14.3.8 Ortho Clinical
14.3.9 Fujirebio
14.3.10 Mediwatch (LABORIE)
14.3.11 BodiTech
